These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8739396)
1. Inflammatory mechanisms in Alzheimer's disease. Hüll M; Strauss S; Berger M; Volk B; Bauer J Eur Arch Psychiatry Clin Neurosci; 1996; 246(3):124-8. PubMed ID: 8739396 [TBL] [Abstract][Full Text] [Related]
2. The participation of interleukin-6, a stress-inducible cytokine, in the pathogenesis of Alzheimer's disease. Hüll M; Strauss S; Berger M; Volk B; Bauer J Behav Brain Res; 1996 Jun; 78(1):37-41. PubMed ID: 8793035 [TBL] [Abstract][Full Text] [Related]
3. Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques. Hüll M; Berger M; Volk B; Bauer J Ann N Y Acad Sci; 1996 Jan; 777():205-12. PubMed ID: 8624085 [TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 is present in early stages of plaque formation and is restricted to the brains of Alzheimer's disease patients. Huell M; Strauss S; Volk B; Berger M; Bauer J Acta Neuropathol; 1995; 89(6):544-51. PubMed ID: 7676810 [TBL] [Abstract][Full Text] [Related]
7. Microglial interleukin-1 alpha expression in brain regions in Alzheimer's disease: correlation with neuritic plaque distribution. Sheng JG; Mrak RE; Griffin WS Neuropathol Appl Neurobiol; 1995 Aug; 21(4):290-301. PubMed ID: 7494597 [TBL] [Abstract][Full Text] [Related]
8. Plaque-associated neuronal proteins: a recurrent motif in neuritic amyloid deposits throughout diverse cortical areas of the Alzheimer's disease brain. Schmidt ML; DiDario AG; Otvos L; Hoshi N; Kant JA; Lee VM; Trojanowski JQ Exp Neurol; 1994 Dec; 130(2):311-22. PubMed ID: 7867760 [TBL] [Abstract][Full Text] [Related]
9. Identification in immunolocalization of a new class of proteoglycan (keratan sulfate) to the neuritic plaques of Alzheimer's disease. Snow AD; Nochlin D; Sekiguichi R; Carlson SS Exp Neurol; 1996 Apr; 138(2):305-17. PubMed ID: 8620929 [TBL] [Abstract][Full Text] [Related]
10. Interleukin-1 expression in different plaque types in Alzheimer's disease: significance in plaque evolution. Griffin WS; Sheng JG; Roberts GW; Mrak RE J Neuropathol Exp Neurol; 1995 Mar; 54(2):276-81. PubMed ID: 7876895 [TBL] [Abstract][Full Text] [Related]
11. [Pro-inflammatory cytokines in Alzheimer's disease]. Stamouli EC; Politis AM Psychiatriki; 2016; 27(4):264-275. PubMed ID: 28114090 [TBL] [Abstract][Full Text] [Related]
12. Application of triple immunohistochemistry to characterize amyloid plaque-associated inflammation in brains with Alzheimer's disease. Dandrea MR; Reiser PA; Gumula NA; Hertzog BM; Andrade-Gordon P Biotech Histochem; 2001 Mar; 76(2):97-106. PubMed ID: 11440311 [TBL] [Abstract][Full Text] [Related]
13. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Sheng JG; Mrak RE; Griffin WS Acta Neuropathol; 1997 Jul; 94(1):1-5. PubMed ID: 9224523 [TBL] [Abstract][Full Text] [Related]
14. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model. Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821 [TBL] [Abstract][Full Text] [Related]
15. Amyloid beta plaque-associated proteins C1q and SAP enhance the Abeta1-42 peptide-induced cytokine secretion by adult human microglia in vitro. Veerhuis R; Van Breemen MJ; Hoozemans JM; Morbin M; Ouladhadj J; Tagliavini F; Eikelenboom P Acta Neuropathol; 2003 Feb; 105(2):135-44. PubMed ID: 12536224 [TBL] [Abstract][Full Text] [Related]
16. [Expression of apolipoprotein E in Alzheimer's disease and its significance]. He SR; Liu DG; Wang S; Xia YJ Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 and alpha-2-macroglobulin indicate an acute-phase state in Alzheimer's disease cortices. Bauer J; Strauss S; Schreiter-Gasser U; Ganter U; Schlegel P; Witt I; Yolk B; Berger M FEBS Lett; 1991 Jul; 285(1):111-4. PubMed ID: 1712317 [TBL] [Abstract][Full Text] [Related]
18. The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Eikelenboom P; Veerhuis R Neurobiol Aging; 1996; 17(5):673-80. PubMed ID: 8892339 [TBL] [Abstract][Full Text] [Related]
19. Neuropathology of Alzheimer's disease: a critical update. Jellinger KA; Bancher C J Neural Transm Suppl; 1998; 54():77-95. PubMed ID: 9850917 [TBL] [Abstract][Full Text] [Related]
20. [Expression of cytokine IL-1α and S100β in different types of plaques in Alzheimer's disease]. Yao JJ; He SR; Chen L; Yang L; Qiao XB; Zhang W; Du J; Liu DG Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):581-4. PubMed ID: 22177239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]